NCT02182739View on ClinicalTrials.gov

Observational Study of Meloxicam in Any Labeled Indication

CompletedOBSERVATIONAL
Enrollment

13,039

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

December 31, 2001

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Meloxicam

tablets or injectable solution

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY